52W $16.34 – $35.75
Sanara MedTech Inc.
Revenue breakdown: Soft Tissue Repair Products (86.4%), Bone Fusion Products (13.5%), Royalty (0.1%).
Results of Operations and Financial Condition. On March 24, 2026, Sanara MedTech Inc. (the “Company”) issued a press release announcing its financial results fo
of this Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is required
Results of Operations and Financial Condition. On January 23, 2026, Sanara MedTech Inc. (the “Company”) issued a press release announcing certain preliminary fi
Revenue by Segment